医学
血糖性
冠状动脉疾病
内科学
随机对照试验
2型糖尿病
临床终点
糖尿病
心脏病学
析因分析
2型糖尿病
内分泌学
胰岛素
作者
Yu Kataoka,Satoshi Kitahara,Sayaka Funabashi,Hisashi Makino,Masaki Matsubara,Miki Matsuo,Yoko Omura‐Ohata,Ryo Koezuka,Mayu Tochiya,Tamiko Tamanaha,Tsutomu Tomita,Kyoko Honda-Kohmo,Michio Noguchi,M Maruki,Emi Kanai,Kota Murai,Takamasa Iwai,Kenichiro Sawada,Hideo Matama,Satoshi Honda
标识
DOI:10.1016/j.jdiacomp.2023.108592
摘要
CGM-guided control for 48 weeks did not slow disease progression in T2DM patients with CAD. A greater regression of lipidic plaque under CGM-guided glycemic control in the post-hoc analysis requires further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI